Prof. Dr. med.

Luregn

Schlapbach, PhD, FCICM

2020: PhD (The University of Queensland)
2014: Associate Professor, School of Medicine, University of Queensland, Brisbane
2004: MD Thesis, Medical Faculty, University of Basel, Switzerland

Aktuell: Head of Department of Intensive Care and Neonatology, University Children’s Hospital Zürich, Switzerland
2014-2020: Consultant Paediatric Intensive Care Unit, Queensland Children’s Hospital, Brisbane, Australia
2014-2016: Director Children’s Critical Care Services, Gold Coast University Hospital, Southport, Australia
2013-2014: Consultant Paediatric Intensive Care Unit, Mater and Royal Children’s Hospital, Brisbane, Australia
2011-2012: Fellow at Paediatric Intensive Care Unit, Mater Children’s Hospital, Brisbane, Australia
2009-2010: Consultant Neonatal and Paediatric Intensive Care Unit, University Children’s Hospital Bern, Switzerland
2004-2008: Training in Pediatrics, Neonatology and Intensive Care in Bellinzona, Bern und Kinderspital Zürich

Specialist in Intensive Care Medicine, CICM, College of Intensive Care of Australia and New Zealand
Specialist in Neonatology, Swiss Federal Board Examination in Neonatology, Swiss Society of Neonatology, Swiss Medical Association (FMH)
Specialist in Intensive Care Medicine, Swiss Federal Board Examination in Intensive Care Medicine: passed, Swiss Society of Intensive Care Medicine, Swiss Medical Association (FMH)
Specialist in Paediatrics, Swiss Federal Board Examination in Pediatrics, Swiss Society of Paediatrics, Swiss Medical Association (FMH)
Swiss Federal Medical Board Exam, University of Basel

• 2020 Global Sepsis Award: category «Governments and Healthcare Authorities»
• 2014/2015/2017 ANZICS Award for the best paediatric paper
• 2014 ANZICS CORE Award for the best paper
• 2010 Talent prize of the Swiss Society of Pediatrics
• 2010 Milupa Fellowship Award of the Swiss Society of Neonatology

• Swiss Medical Association (FMH) and VSAO
• Swiss Society of Neonatology (SGN)
• Swiss Society of Paediatrics (SGP)
• Swiss Society of Intensive Care (SGI)
• Pediatric Infectious Diseases Group Switzerland (PIGS)
• European Society of Neonatal and Paediatric Intensive Care Medicine (ESPNIC), Chair Section Infection, Inflammation and Sepsis
• European Society of Intensive Care Medicine (ESICM)
• College of Intensive Care Medicine of Australia and New Zealand (CICM)
• Australian and New Zealand Intensive Care Society (ANZICS)
• Society of Critical Care Medicine (SCCM)

• Sepsis, Infection and Inflammation
• Critical Care Trials
• Patient outcomes and quality

• Swiss National Science Foundation 320030_201060/1: Machine Learning in the Swiss Pediatric Sepsis Study; role: Chief investigator A
• National Institute of Health 1 R01 HD105939 (lead: Tellen Bennet): Pediatric Sepsis Criteria and Clinical Decision Support Tools; role: Principal investigator
• Medical Research Future Fund GHFM76734: Host Gene-expression signatures to diagnose sepsis in children; role: Chief investigator A
• Medical Research Future Fund RGCHDG000036: Gene Expression to Predict Long Term Outcome in Infants After Heart Surgery; role: Chief investigator A
• NOMIS, Vontobel Stiftung, Fondation Gaydoul: Recovery PIMS; role: Principal investigator
• Wolfermann-Nägeli-Stiftung: Sepsis; role Chief investigator
• Borer Vinetum Foundation: Neurodevelopmental Follow-up Swiss Pediatric Sepsis Study; role: Coinvestigator

• ORCID
• Google Scholar-ID